Customers should use only the medication, syringe units, concentration, and schedule printed on their prescription and dispensing label
Insomnia was not among the most prominently reported adverse events in published phase 2 trial data, though gastrointestinal side effects such as nausea may indirectly disrupt sleep
According to FDA-approved labeling, the potency and sterility of GLP-1 medications cannot be assured beyond the recommended timeframes

*AR : apport de rfrence pour un adulte Ingrdients - saveur pche : sucre, maltodextrines, glucose, fructose, correcteur d'acidit (acide citrique), correcteur d'acidit (acide malique), chlorure de sodium, sels de potassium de l'acide ortho phosphorique, sels de calcium de l'acide ortho phosphorique, citrate de sodium, carbonate de magnsium, paississant (gomme arabique), paississant (gomme de xanthane), paississant (carboxymthylcellulose de sodium), armes, l-glutamine, l-carnitine-L-tartrate, acide L-ascorbique (vitamine C), d-alpha-tocophryl-actate, niacine (nicotinamide), biotine (vitamine D), actate de rtinyle (vitamine A), pantothnate de calcium, chlorhydrate de pyridoxine (vitamine B6), cholcalcifrol (vitamine D), mononitrate de thiamine (vitamine B1), riboflavine (vitamine B2), cyanocobalamine (vitamine B12), dulcorants (acesulfame-K, sucralose), colorant E150c